1991
DOI: 10.3109/10641969109045063
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Chronic Opioid Delta Receptor Antagonism on Blood Pressure Development and Tissue Contents of Catecholamines and Endogenous Opioids in Spontaneously Hypertensive Rats

Abstract: Opioid delta receptors seem to be involved in blood pressure regulation of spontaneously hypertensive rats (SHR), possibly by an interaction with the sympathetic nervous system. In the present study the effect of four weeks' chronic delta receptor antagonism with ICI 154 129 on development of blood pressure was evaluated in young SHR. Contents of adrenaline and noradrenaline and the opioid peptides beta-endorphin and leucine-enkephalin were measured in brain stem, mid brain, hypothalamus, and adrenal glands. A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1991
1991
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…In our work we did not observe an effect of NTI on BP level; however, another group has demonstrated that in young hypertensive SHR rats, four weeks of antagonism of δ opioid receptors by ICI 154 129 compound (10 µg/h sc.) caused a lowering of BP seen after 3 weeks of treatment (with measurements performed twice a week) [ 55 ]. In these chronically treated rats, an increase in β-endorphins but not enkephalins has been detected in the hypothalamus, which reflects the initiation of compensatory processes, counteracting the persistent inhibition of δ opioid receptors by the reprogramming of opioid peptide synthesis towards the enhanced production of endogenous ligands for unoccupied µ opioid receptors [ 55 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In our work we did not observe an effect of NTI on BP level; however, another group has demonstrated that in young hypertensive SHR rats, four weeks of antagonism of δ opioid receptors by ICI 154 129 compound (10 µg/h sc.) caused a lowering of BP seen after 3 weeks of treatment (with measurements performed twice a week) [ 55 ]. In these chronically treated rats, an increase in β-endorphins but not enkephalins has been detected in the hypothalamus, which reflects the initiation of compensatory processes, counteracting the persistent inhibition of δ opioid receptors by the reprogramming of opioid peptide synthesis towards the enhanced production of endogenous ligands for unoccupied µ opioid receptors [ 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…caused a lowering of BP seen after 3 weeks of treatment (with measurements performed twice a week) [ 55 ]. In these chronically treated rats, an increase in β-endorphins but not enkephalins has been detected in the hypothalamus, which reflects the initiation of compensatory processes, counteracting the persistent inhibition of δ opioid receptors by the reprogramming of opioid peptide synthesis towards the enhanced production of endogenous ligands for unoccupied µ opioid receptors [ 55 ]. Since µ opioid receptor agonism usually contributes to hypotension, the effect authors observed likely could be assigned to β-endorphin action.…”
Section: Discussionmentioning
confidence: 99%